Dr. Gong Wei (龚伟) — Biliary & Pancreatic Disease | Shanghai Biliary Disease Research Center | Xinhua Hospital
For international patients with complex biliary or pancreatic diseases — including cholangiocarcinoma, gallbladder cancer, bile duct stones, biliary strictures, and pancreatic tumors — Dr. Gong Wei (龚伟) at Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, holds a unique institutional position: he is simultaneously the Director of the Department of General Surgery and the Director of the Shanghai Biliary Disease Research Center — the city's dedicated research institution for biliary tract diseases. This dual leadership role places Dr. Gong at the intersection of clinical practice and research in one of China's most active biliary disease programs.
Specialty Focus
- Biliary tract diseases: cholangiocarcinoma, gallbladder cancer, bile duct stones, biliary strictures, primary sclerosing cholangitis
- Pancreatic diseases: pancreatic cancer, pancreatic cysts, chronic pancreatitis, pancreatic endocrine tumors
- Complex biliary reconstruction surgery
- Minimally invasive biliary and pancreatic surgery
- Multidisciplinary management of biliary-pancreatic malignancies
Academic & Clinical Titles
- Chief Physician & Professor, Director of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Director, Shanghai Biliary Disease Research Center (上海市胆道疾病研究中心)
- Committee Member and Secretary, Biliary Surgery Group, Surgery Branch, Chinese Medical Association (CMA)
- Principal investigator in multiple national research programs on biliary tract diseases
The Shanghai Biliary Disease Research Center
The Shanghai Biliary Disease Research Center, which Dr. Gong Wei directs, is a dedicated institutional platform for advancing the diagnosis, treatment, and understanding of biliary tract diseases. As a research center focused specifically on biliary diseases — rather than a general surgical research program — it concentrates expertise, resources, and clinical data in a way that benefits patients with these conditions directly.
For international patients, the existence of this research center at Xinhua Hospital means that Dr. Gong's clinical practice is continuously informed by the latest research findings, and that patients treated at his center contribute to and benefit from an ongoing program of clinical investigation. Patients with rare or complex biliary conditions — including unusual presentations of cholangiocarcinoma, complex biliary strictures, or biliary complications of prior surgery — are particularly likely to benefit from this research-informed clinical environment.
National Leadership in Biliary Surgery
Dr. Gong Wei's role as Committee Member and Secretary of the Biliary Surgery Group of the Chinese Medical Association's Surgery Branch places him at the center of national biliary surgery practice. The CMA's biliary surgery group is the professional body responsible for setting standards, developing guidelines, and advancing the field of biliary surgery across China. As secretary of this group, Dr. Gong is not only a practitioner of biliary surgery but an active participant in shaping how it is practiced nationally.
This national leadership role means that Dr. Gong's clinical practice reflects the most current national and international standards for biliary surgery, and that his patients benefit from his awareness of emerging evidence, new techniques, and evolving treatment paradigms across the field.
Biliary Tract Cancers: Dr. Gong's Clinical Approach
Biliary tract cancers — including cholangiocarcinoma (intrahepatic, hilar, and distal) and gallbladder cancer — are among the most challenging malignancies in gastrointestinal oncology. They are often diagnosed at an advanced stage, have limited sensitivity to standard chemotherapy, and require highly specialized surgical expertise when resection is possible.
Surgical resection remains the only potentially curative treatment for biliary tract cancers. Achieving R0 (clear margin) resection is the most important prognostic factor, but it often requires complex operations including major hepatectomy, bile duct resection with reconstruction, portal vein resection, and extensive lymphadenectomy. Dr. Gong's surgical expertise, developed over years of high-volume biliary surgery practice at a dedicated research center, enables him to perform these technically demanding operations with the precision required for optimal outcomes.
Molecular profiling has become essential in biliary tract cancer management. Actionable alterations including FGFR2 fusions (in intrahepatic CCA), IDH1 mutations, HER2 amplification (more common in gallbladder cancer), BRAF V600E mutations, and MSI-H status can guide targeted therapy selection. Dr. Gong's team integrates comprehensive molecular profiling into the diagnostic workup for all biliary tract cancer patients.
Multidisciplinary management is central to Dr. Gong's approach. Complex biliary tract cancer cases are reviewed by a multidisciplinary tumor board including hepatobiliary surgery, medical oncology, radiation oncology, interventional radiology, and pathology — ensuring that treatment decisions reflect the full range of available options and the collective expertise of multiple specialists.
Pancreatic Diseases: Comprehensive Expertise
Beyond biliary diseases, Dr. Gong has extensive expertise in the surgical management of pancreatic conditions:
Pancreatic cancer: Surgical resection (Whipple procedure for pancreatic head tumors, distal pancreatectomy for body/tail tumors) is the only potentially curative treatment. Dr. Gong's experience with complex pancreatic resections, including vascular reconstruction when portal vein or superior mesenteric vein involvement is present, enables him to operate on cases that may be deemed unresectable at lower-volume centers.
Pancreatic cystic lesions: The management of pancreatic cysts — including intraductal papillary mucinous neoplasms (IPMNs), mucinous cystic neoplasms, and serous cystadenomas — requires careful risk stratification to identify lesions with malignant potential that require resection versus those that can be safely monitored. Dr. Gong's expertise in this area helps patients avoid unnecessary surgery while ensuring that high-risk lesions are appropriately treated.
Pancreatic neuroendocrine tumors (PNETs): These tumors have distinct biology and treatment considerations compared to pancreatic adenocarcinoma, including the potential for surgical cure even in the presence of liver metastases in selected cases.
Who Should Consider Consulting Dr. Gong Wei
- Patients with cholangiocarcinoma (intrahepatic, hilar, or distal) seeking surgical evaluation or second opinion
- Patients with gallbladder cancer at any stage
- Patients with complex biliary strictures or biliary complications of prior surgery
- Patients with pancreatic cancer seeking surgical evaluation, including borderline resectable cases
- Patients with pancreatic cystic lesions requiring risk stratification and management planning
- Patients with primary sclerosing cholangitis or other complex benign biliary diseases
- Patients seeking access to clinical trials for biliary tract malignancies
How CMCS Connects You with Dr. Gong Wei
China Medical Concierge Shanghai (CMCS) facilitates access to Dr. Gong Wei for international patients with biliary and pancreatic diseases. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including CT and/or MRI with biliary/pancreatic protocol, MRCP if available, pathology reports, molecular profiling results, tumor markers (CA 19-9, CEA, AFP), liver and pancreatic function tests, and prior treatment summaries. Dr. Gong's team can conduct an initial remote assessment before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review and resectability assessment
- Appointment coordination with Dr. Gong Wei's clinic at Xinhua Hospital
- On-site interpretation during consultations and procedures
- Molecular profiling coordination and targeted therapy eligibility assessment
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Dr. Gong Wei
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 commentaire